- Home
- DUO vs QNRX Comparison
DUO vs QNRX Comparison
Compare DUO & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUO
- QNRX
- Stock Information
- Founded
- DUO 2011
- QNRX 2018
- Country
- DUO China
- QNRX United States
- Employees
- DUO N/A
- QNRX N/A
- Industry
- DUO Real Estate
- QNRX Medical/Dental Instruments
- Sector
- DUO Finance
- QNRX Health Care
- Exchange
- DUO Nasdaq
- QNRX Nasdaq
- Market Cap
- DUO 6.1M
- QNRX 5.2M
- IPO Year
- DUO 2019
- QNRX N/A
- Fundamental
- Price
- DUO $1.82
- QNRX $18.30
- Analyst Decision
- DUO
- QNRX
- Analyst Count
- DUO 0
- QNRX 0
- Target Price
- DUO N/A
- QNRX N/A
- AVG Volume (30 Days)
- DUO 185.6K
- QNRX 1.0M
- Earning Date
- DUO 11-19-2025
- QNRX 11-06-2025
- Dividend Yield
- DUO N/A
- QNRX N/A
- EPS Growth
- DUO N/A
- QNRX N/A
- EPS
- DUO N/A
- QNRX N/A
- Revenue
- DUO $56,189,313.00
- QNRX N/A
- Revenue This Year
- DUO N/A
- QNRX N/A
- Revenue Next Year
- DUO N/A
- QNRX N/A
- P/E Ratio
- DUO N/A
- QNRX N/A
- Revenue Growth
- DUO 48.30
- QNRX N/A
- 52 Week Low
- DUO $1.24
- QNRX $5.01
- 52 Week High
- DUO $24.64
- QNRX $48.30
- Technical
- Relative Strength Index (RSI)
- DUO 35.53
- QNRX 71.06
- Support Level
- DUO $1.76
- QNRX $8.05
- Resistance Level
- DUO $2.20
- QNRX $14.03
- Average True Range (ATR)
- DUO 0.16
- QNRX 2.15
- MACD
- DUO 0.02
- QNRX 0.74
- Stochastic Oscillator
- DUO 6.38
- QNRX 99.47
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.